LevEllis, Inc. is launching Provoque, a new skincare serum comprised of proprietary secretome technology derived from human skin progenitor cells.
The skin-specific secretome comprises a matrix of peptides, growth factors, cytokines, microRNA, exosomes, and regenerative molecules. The physician-dispensed medical-grade serum is free from fragrances, detergents, oils, and organic solvents.
“What truly distinguishes PROVOQUE is that it is built upon skin-specific cellular science. These young, bioengineered skin progenitor cells produce the complete skin secretome—a robust, biologically active blend of naturally occurring growth factors, exosomes, and the glycoprotein Fetuin-A,” says Hans Keirstead, PhD, Inventor of the PROVOQUE technology, in a news release. “A dermatology-assessed, peer-reviewed study published in Journal of Drugs in Dermatology shows it reveals healthier, smoother-looking skin from the inside out in as early as 14 days.” (See results below.)
” 
